Thailand is emerging as a powerhouse in the global medical cannabis market, boasting a remarkable local sales figure of $1.2 billion. The nation not only leads in market size but is also investing heavily in the industry. Recent developments include state-of-the-art indoor cultivation facilities and collaboration with top-tier growers from California and Canada, all designed to elevate quality standards.
While the United States took two decades to establish itself as the top market, Thailand is fast-tracking its growth by leveraging U.S. expertise. With a wealth of skilled farmers, a strong pharmaceutical workforce, and substantial financial backing, Thailand has the potential to outpace Canada as the leading exporter in the medical cannabis sector this decade, acting as a gateway for the burgeoning markets of Asia, including the Philippines and Laos, which are on the brink of legalization.
Funding the Cannabis Explosion in Thailand
Starting a cannabis business can be quite an expensive endeavor. With fierce competition from large public companies and pharmaceutical entities, along with the hefty costs of pharmaceutical regulations, the financial stakes are higher than ever. A decade ago, thousands of entrepreneurs were brimming in Canada, but the market faced challenges, leading to a notable overbuilding.
Despite steady growth in the U.S. cannabis industry, attention has shifted towards global medical markets for new growth opportunities, where capital is essential for survival. International players have seen many small, undercapitalized companies fade away quickly. Thailand, however, is buoyed by substantial local and regional investments, envisioning a future market valued between $100 to $200 billion. This broad backing positions Thailand as a strategic gateway to both Asian and European cannabis markets.
Cross-Border Cannabis Competition
The Canadian cannabis market stands out for its efficiency, boasting some of the lowest export costs for premium products globally. In contrast, Thailand possesses the ability to produce both economical cannabis and top-tier flower, positioning itself as a competitive player in the international arena.
As Thailand ramps up production, it poses a significant challenge to Canada in the global market. With substantial volumes of cannabis ready to enter the United Kingdom, Germany, Australia, and various international markets, the influx is likely to exert downward pressure on prices. Australian markets are already feeling this effect, as both Canadian and Thai producers vie for client bases across Europe.
The surge in demand in Germany illustrates a growing appetite for cannabis. However, the market struggles to keep pace with the anticipated increase in supply, posing challenges for the distribution network.
Internal and External Growth for Thailand
With a robust internal market valued at $1.2 billion, Thailand’s cannabis sector is expanding rapidly. Supported by thousands of dispensaries, robust tourism, and relatively easy access for consumers, the nation is poised to dominate in medical cannabis. Predictions suggest that as Germany’s market aims for one billion euros, it will still lag behind Thailand’s expansive internal economy.
Thai agriculture benefits from an abundance of outdoor cultivation capabilities, although the tropical climate presents unique challenges. The nation has seen 1.1 million registrations for cannabis growers, many of whom are likely to shift towards indoor growing for better control over environmental conditions. This transition is expected to yield some of the world’s finest premium cannabis.
Though the bulk of Thai-produced cannabis will likely remain for local consumption due to barriers in achieving international quality standards, fluctuations in pricing could amplify pressure from global markets. Furthermore, the impending legalization movements in neighboring countries like the Philippines and Laos indicate that a regional market boom might soon follow.
A Bright Future for Medical Cannabis in Thailand and Beyond
Thailand’s internal market supports a promising outlook for its cannabis industry, with expectations to further scale its export capacity to Europe, Australia, and beyond. As it continues to evolve, Thailand is set to become the central hub for cannabis technology and cultivation in Asia, paving the way for newer entrants into the global market.
There’s credibility behind the prediction that Thailand may soon overtake Canada as the foremost exporter to global markets. This shift could benefit Europe, providing access to affordable, high-quality indoor-grown cannabis, and granting international patients the opportunity to experience state-of-the-art Thai products.
Michael Sassano is the CEO of Somai Pharmaceuticals.